| Amanda Marie Brothers, MA CCC-SLP | |
|
2411 E Main St, Danville, IN 46122-8466 | |
| (317) 718-0089 | |
| Not Available |
| Full Name | Amanda Marie Brothers |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2411 E Main St, Danville, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740537737 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 22005751A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amanda Marie Brothers, MA CCC-SLP 2411 E Main St, Danville, IN 46122-8466 Ph: (317) 718-0089 | Amanda Marie Brothers, MA CCC-SLP 2411 E Main St, Danville, IN 46122-8466 Ph: (317) 718-0089 |
News Archive
The recommendation to delay noncardiac surgery for a year after receipt of a drug-eluting stent, compared with just 6 weeks for a bare-metal stent, may be too conservative, suggests research indicating that stent type does not influence the longer term risk for major adverse cardiac events.
St. Jude Medical, Inc., a global medical device company, today announced the publication of results from an economic evaluation of the landmark FAME (Fractional Flow Reserve (FFR) vs. Angiography in Multivessel Evaluation) trial, which confirmed FFR-guided percutaneous coronary intervention (PCI) in patients with multivessel coronary artery disease improves patient outcomes and offers cost-saving benefits to the U.S. healthcare system.
Researchers have revealed the initial results from the world's largest comprehensive study of hypertrophic cardiomyopathy, an abnormal thickening of the heart that often goes undiagnosed and can prove deadly. The condition can present at any age, and it is the most common cause of sudden cardiac death in young athletes.
OncoSec Medical Inc., a therapeutic oncology company developing innovative medical approaches to treat solid tumor cancers with unmet medical needs, announced today the cancer therapy company's tumor-destroying, tissue-sparing drug/device technology was profiled in Medical Device Daily, the news source for the high-tech medical technology industry that is relied on by thousands of industry insiders every business morning.
› Verified 1 days ago
Mrs. Hillary N Rudolphi, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3380 E Main St, Danville, IN 46122 Phone: 317-718-0089 | |
Alison Marshall Winters, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1001 Sycamore Ln, Danville, IN 46122 Phone: 317-745-7503 | |
Tammy Navarro, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 E Main St, Danville, IN 46122 Phone: 317-745-3414 | |
Sarah Wanger, M.S., CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3380 E Main St, Danville, IN 46122 Phone: 317-718-0089 Fax: 317-718-0097 | |
Ms. Jennifer Laine Hagemeyer, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1001 Sycamore Ln, Danville, IN 46122 Phone: 317-745-4715 | |
Mrs. Teresa A Nering, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1001 Sycamore Ln, Danville, IN 46122 Phone: 317-745-7066 | |
Michelle Jordan, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1001 Sycamore Ln, Danville, IN 46122 Phone: 317-745-4715 Fax: 317-745-8271 |